IMMvention Therapeutix
Marilyn Thompson is an experienced business development executive with over 25 years of experience in the biotech, pharma, medical device/software, and 3D scanning sectors.
She has served as a Controller, Director of Finance, VP of Finance, and Chief Financial Officer with oversight of Accounting, Finance, and administrative areas of business. She has extensive experience in new business and has served as a consultant to over 100 start-up companies.
Marilyn has managed millions of dollars in NIH and NSF funded grants and continues to consult with companies concerning grant funding. Ms. Thompson attended East Carolina University where she majored in Business with a degree in Accounting.
This person is not in any offices
IMMvention Therapeutix
IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that is at the root cause of some of the following diseases.